Rapid identification of novel functional promoters for gene therapy (2012)

Pringle, I. A., Gill, D. R., Connolly, M. M., Lawton, A. E., Hewitt, A.-M., Nunez-Alonso, G., Cheng, S. H., Scheule, R. K., Davies, L. A. & Hyde, S. C.

Journal of Molecular Medicine, In Press.

Pubmed     Back

Transcriptional control of transgene expression is crucial to successful gene therapy, yet few promoter/enhancer combinations have been tested in clinical trials. We created a simple, desktop computer database and populated it with promoter sequences from publicly available sources.

From this database, we rapidly identified novel CpG-free promoter sequences suitable for use in non-inflammatory, non-viral in vivo gene transfer. In a simple model of lung gene transfer, all six promoter elements selected, chosen without prior knowledge of their transcriptional activities, directed significant transgene expression. Five of the six promoters evaluated, directed transgene expression for at least 14 days post delivery, greatly exceeding the duration achieved with the commonly used CpG-rich CMV enhancer/promoter.

Novel promoter activity was also evaluated in a more clinically relevant model of aerosol mediated lung gene transfer and in the liver following delivery via high-pressure tail vein injection. In each case the novel CpG-free promoters exhibited higher and/or more sustained transgene expression than commonly used CpG-rich enhancer/promoter sequences.

This study demonstrates that novel CpG-free promoters can be readily identified and that they can direct significant levels of transgene expression. Furthermore the database search criteria can be quickly adjusted to identify other novel promoter elements for a variety of transgene expression applications.

Introductory Videos
Medical Futures Innovation Award 2011
Twitter Feed
About Us
Contact Us
Lab Events
Environemental Policy
About this Site

Google Site Search

Site Feedback Form

All Site Images



How the Consortium works/FAQs

Consortium Website

Centre for Molecular Medicine, Edinburgh
The Roslin Institute
Dep of Gene Therapy, Imperial



The Run-in Study

Single Dose Clinical Trial

Multi Dose Clinical Trial


Our Research

Non-viral Vector Development

Aerosol Mediated Gene Delivery

Viral Vector Development

Taqman Core Facility

Cystic Fibrosis

History of CF

Discovery of the CFTR Gene

CFTR Protein Structure

CFTR Function

CF Links


Gene Therapy

Introduction to Gene Therapy

Other CF Gene Therapy Groups

Why use Gene Therapy for CF

Target Cells for CF Gene Therapy

Barriers for CF Gene Therapy

Clinical Trials

Gene Therapy Successes

Gene Therapy Links




Papers in Journals

Conference Posters & Presentations

Book Chapters

D.Phil Theses



Gene Therapy Seminars


Directions & Venue